Hangzhou Tigermed Consulting (03347) recommends appointing Xiao Yaoxi as an independent non-executive director.
Tiger Pharmaceutical (03347) issued a notice, according to the recommendation of the Nomination Committee, the Board of Directors proposes: (1) to re-elect Dr. Ye Xiaoping, Ms. Cao Xiaochun, and Mr. Wen Zengyu as executive directors of the sixth board of directors; (2) to re-elect Mr. Yuan Huagang and Ms. Liu Yuwen as independent non-executive directors of the sixth board of directors; and (3) to appoint Mr. Xiao Yaoxi as an independent non-executive director of the sixth board of directors.
Hangzhou Tigermed Consulting (03347) announced that based on the recommendation of the Nomination Committee, the Board of Directors proposes: (1) to re-elect Dr. Ye Xiaoping, Ms. Cao Xiaochun, and Mr. Wen Zengyu as executive directors of the 6th Board of Directors; (2) to re-elect Mr. Yuan Huagang and Ms. Liu Yuwen as independent non-executive directors of the 6th Board of Directors; and (3) to appoint Mr. Xiao Yaoxi as an independent non-executive director of the 6th Board of Directors.
Related Articles

JOYZYME GROUP (08622): Xu Ming resigns as non-executive director.
HYGEIA HEALTH (06078) announced that its net profit for 2025 is approximately 161.5 million yuan, a decrease of 73.0% year-on-year.

Zhou Hei Ya (01458) spent HK $21,200 on March 30 to repurchase 15,000 shares.
JOYZYME GROUP (08622): Xu Ming resigns as non-executive director.

HYGEIA HEALTH (06078) announced that its net profit for 2025 is approximately 161.5 million yuan, a decrease of 73.0% year-on-year.
Zhou Hei Ya (01458) spent HK $21,200 on March 30 to repurchase 15,000 shares.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


